2024年3月至4月西班牙由表达罕见porA基因亚型(19-54, 15)的B群脑膜炎球菌引起的侵袭性脑膜炎球菌病暴发
2024年3月至4月西班牙发生侵袭性脑膜炎球菌病暴发,涉及4名年轻成人,病死率高,其中2例死亡。所有病例均鉴定为具有相同特征的B群脑膜炎球菌(B: 19-54, 15: F5-1: ST-34, cc32),其PorA_VR1基因亚型19-54此前未见报道。通过人血清杀菌抗体试验测定4CMenB疫苗对该暴发菌株的杀菌反应,将其定义为疫苗覆盖菌株。公共卫生当局对超过200名密切接触者开展主动搜索,并建议及时进行化学预防和/或接种4CMenB疫苗。
要点
- 2024年3–4月西班牙4名年轻成人发生侵袭性脑膜炎球菌病暴发,2例死亡。
- 暴发菌株为B群脑膜炎球菌(B: 19-54, 15: F5-1: ST-34, cc32),PorA_VR1基因亚型19-54此前未见报道。
- 4CMenB疫苗对该暴发菌株的覆盖通过人血清杀菌抗体试验测定,并定义为覆盖。
核心结论
- 2024年3月至4月西班牙由表达罕见porA基因亚型19-54的B群脑膜炎球菌引起侵袭性脑膜炎球菌病暴发,累及4名年轻成人,其中2例死亡。
- 应密切监测具有基因亚型19-54的脑膜炎球菌菌株的演变,因其可能赋予更强的传播能力。
研究设计与样本
- 2024年3月至4月西班牙暴发调查,报告4例侵袭性脑膜炎球菌病年轻成人病例。
主要发现
- 病例1和病例4通过从血液样本中分离出脑膜炎奈瑟菌确诊,病例2和病例3通过脑脊液PCR确诊。
- 所有病例鉴定为具有相同特征的B群脑膜炎球菌(B: 19-54, 15: F5-1: ST-34, cc32)。
- 暴发菌株基因亚型PorA_VR1: 19-54此前未被描述。
- 通过人血清杀菌抗体试验测定4CMenB疫苗对暴发菌株的杀菌反应,将该菌株定义为疫苗覆盖。
- 两次不同的社交活动涉及暴发菌株的传播。
关键数值与推荐
- 根据国家脑膜炎球菌病监测方案,公共卫生当局对病例的密切接触者开展主动搜索。
- 建议对超过200名接触者及时进行化学预防和/或接种4CMenB疫苗。
临床怎么用
- 根据国家脑膜炎球菌病监测方案,公共卫生当局对病例的密切接触者开展主动搜索。
- 建议对超过200名接触者及时进行化学预防和/或接种4CMenB疫苗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In Spain during March-April 2024, an outbreak of invasive meningococcal disease (IMD) occurred in four young adults, exhibiting high case fatality with two deaths. Cases 1 and 4 were confirmed by isolation of Neisseria meningitidis from blood samples, while Cases 2 and 3 were PCR-confirmed from cerebrospinal fluid (CSF). Serogroup B meningococcus with identical characterisation (B: 19-54, 15: F5-1: ST-34, cc32) was identified for all cases; the outbreak strain genosubtype PorA_VR1: 19-54 had not been previously described. Potential coverage of the outbreak strain by available MenB vaccines could not be predicted by molecular tools, so bactericidal response to the 4CMenB vaccine against the outbreak strain was measured by human serum bactericidal antibody assay (hSBA), defining the strain as covered by the vaccine. Two different social events were involved in transmission of the outbreak strain. According to the national meningococcal disease surveillance protocol, an active search for close contacts of the cases was conducted by public health authorities and timely chemoprophylaxis and/or vaccination with 4CMenB vaccine was recommended to over 200 contacts. The evolution of meningococcal strains with genosubtype 19-54 should be closely monitored, as it might confer a greater transmission capacity.
引用
- Abad R, Navarro C, García-Amil C, et al. Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare porA genosubtype (19-54, 15), Spain, March to April 2024. Euro Surveill. 2025. PMID: 41199706. doi:10.2807/1560-7917.ES.2025.30.44.2500222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。